Thibault Schaeffer

Dr. Thibault Schaeffer

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2024 in International Journal of Cardiology
Verified
Journal Article
Open access
MCMichelle Bao Hoa Nguyen Cong
Michelle Bao Hoa Nguyen Cong
TSThibault Schaeffer
Thibault Schaeffer
TOTakuya Osawa
Takuya Osawa
JPJonas Palm
Jonas Palm
SGStanimir Georgiev
Stanimir Georgiev
MOMasamichi Ono
Masamichi Ono
To evaluate the prevalence of veno-venous collaterals (VVCs) after total cavopulmonary connection (TCPC) and analyze their impact on outcomes. Patients undergoing TCPC between 1994 and 2022 were evaluated. VVCs were identified using angiograms of cardiac catheterizations and their impact on outcomes was analyzed. A total of 635 patients were included. Median age at TCPC was 2.3 (interquartile ranges (IQR): 1.8-3.3) years. The most frequent diagnosis was hypoplastic left heart syndrome in 173 (27.2%) patients. Prior bidirectional cavopulmonary shunt was performed in 586 (92.3%) patients at a median age of 5.3 (3.6-9.9) months. VVCs were found in 94 (14.8%) patients at a median of 2.8 (0.1-11.8) years postoperatively. The prevalence of VVCs was similar between the dominant right and left ventricle (14.7 vs. 14.9%, p = 0.967). Mean pulmonary artery pressure (16.2 vs. 16.0 mmHg, p = 0.902), left atrial pressure (5.5 vs. 5.7 mmHg, p = 0.480), transpulmonary gradient (4.0 vs. 3.8 mmHg, p = 0.554) and oxygen saturation (81.4 vs. 82.6%, p = 0.103) before TCPC were similar between patients with and without VVCs. The development of VVCs did not affect survival after TCPC (p = 0.161). Nevertheless, VVCs were a risk for the development of plastic bronchitis (PB, p < 0.001). Interventional closure of VVCs was performed in 60 (9.4%) patients at a median of 8.9 (0.6-15.1) years after TCPC, and improvement of oxygen saturation was observed in 66% of the patients. The prevalence of VVCs after TCPC was 15%. VVCs had no impact on survival following TCPC but were associated with a high prevalence of PB.

1 January 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
TSThibault Schaeffer
Thibault Schaeffer
DBDenis Berdajs
Denis Berdajs
OROliver Reuthebuch
Oliver Reuthebuch
Cusp tear is an increasingly described mode of failure of the Trifecta aortic bioprosthesis. Acute aortic regurgitation after implantation of a Trifecta in absence of endocarditis should suggest a cusp tear and be promptly treated with redo surgery.

24 February 2025 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
KKKristin Kruse
Kristin Kruse
MMMuneaki Matsubara
Muneaki Matsubara
TSThibault Schaeffer
Thibault Schaeffer
JPJonas Palm
Jonas Palm
FKFrank Klawonn
Frank Klawonn
MOMasamichi Ono
Masamichi Ono
OBJECTIVES: We aimed to determine the incidence of postoperative complete atrioventricular block, the time to recovery or permanent pacemaker implantation and the predictors for postoperative atrioventricular block after congenital heart surgery. METHODS: Patients who underwent open-heart surgery from January 2001 to January 2024 were analysed and predictors of atrioventricular block were identified using a logistic regression model. RESULTS: Among 9765 congenital heart surgeries, 333 (3.4%) were complicated by atrioventricular block, and 193 patients (1.9%) underwent permanent pacemaker implantation. The highest rates of atrioventricular block were found in patients who underwent repair of congenitally corrected transposition of the great arteries (27.3%), followed by Konno procedure (20.0%), mitral valve replacement (16.0%) and arterial switch with closure of ventricular septal defect and arch repair (15.0%). In 134 (1.4%) patients with transient atrioventricular block, the median time to resolution was 4 days (interquartile range: 2–8 days). After 7 postoperative days, 75% had resolved, and after 12 postoperative days, 90% had resolved. Risk factors for the development of atrioventricular block were older age at operation (odds ratio: 1.012, P = 0.001), preoperative endocarditis (2.422, P < 0.001), longer aortic cross-clamp time (1.018, P < 0.001) and high-risk procedures (1.397, P = 0.012). CONCLUSIONS: Postoperative atrioventricular block is not rare after congenital heart surgery, with more than half of them needing permanent pacemaker implantation. Older age at operation, preoperative endocarditis, longer aortic cross-clamp time and high-risk procedures were risks for the development of atrioventricular block. Pacemaker implantation should be delayed to the 12th postoperative day, when 90% of transient blocks have resolved.

21 July 2023 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
TSThibault Schaeffer
Thibault Schaeffer
KGKatharina Glatz
Katharina Glatz
FEFriedrich S Eckstein
Friedrich S Eckstein
PMPeter Matt
Peter Matt
Background: Primary cardiac neoplasm is rare and generally benign. Epithelioid haemangioendothelioma, a potentially malignant tumour of vascular origin, has been occasionally described in the heart. Composite haemangioendothelioma, characterized by a heterogeneous architecture of vascular components and usually located in soft tissue of the extremities, has only been reported twice in the heart. We herein report another case of this extremely uncommon cardiac tumour. Case summary: Comprehensive cardiac examination of a 59-year-old female patient with palpitations and personal history of Hodgkin’s lymphoma and chest radiation revealed a mass in the left atrium. After surgical resection, histopathological and immunohistochemical analysis identified a composite haemangioendothelioma. After two years, repeated imaging revealed neither signs of local relapse nor metastasis. Conclusions: Composite haemangioendothelioma, a very uncommon form of potentially malignant vascular tumour, can also be encountered in the heart. In this present case, the outcome was favourable two years after surgical resection without adjuvant therapy.

28 March 2025 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
AFAndrei Fetcu
Andrei Fetcu
TSThibault Schaeffer
Thibault Schaeffer
CNCarolin Niedermaier
Carolin Niedermaier
JPJonas Palm
Jonas Palm
TOTakuya Osawa
Takuya Osawa
MOMasamichi Ono
Masamichi Ono
OBJECTIVES: This study aimed to investigate the benefits and potential risks of implantable cardioverter-defibrillators in paediatric and congenital heart disease (CHD) patients in the current era. METHODS: All patients with CHD, paediatric cardiomyopathy or primary electrical disease, who underwent implantation of a defibrillator from 2001 to 2023, were examined. The occurrence of appropriate therapy, unplanned surgeries due to device complications, inappropriate shocks and associated risk factors were analysed. RESULTS: A total of 214 patients were included, with 61% having CHD, 17% having paediatric cardiomyopathy and 22% having primary electrical disease. The most common diagnoses were transposition of the great arteries and tetralogy of Fallot (each 12%). The median age at implantation was 23 years (interquartile ranges 15–38), and the median follow-up was 5.7 years (95% confidence interval 4.9—7.3). A total of 196 patients met the criteria for outcome analysis, where appropriate therapy was observed in 41% (n = 80), occurring more often in patients with indications for secondary prevention than primary prevention (56% vs 26% at 5 years, P = 0.003). The cumulative incidence of inappropriate shocks was 13% (n = 26), with patients with CHD being more frequently affected. Unplanned surgeries were required in 36% (n = 71), predominantly due to lead-related issues in those with abdominal generator placement. CONCLUSIONS: The high rate of appropriate therapies underscores the critical importance of risk assessment in ICD selection, particularly to mitigate lead failures and unnecessary shocks. However, defibrillator therapy has a relevant rate of unplanned surgeries, with abdominal generators and epicardial/extracardiac leads being risk factors.

6 May 2025 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
AWAnnabelle Winzig
Annabelle Winzig
MMMuneaki Matsubara
Muneaki Matsubara
JPJonas Palm
Jonas Palm
TSThibault Schaeffer
Thibault Schaeffer
TOTakuya Osawa
Takuya Osawa
MOMasamichi Ono
Masamichi Ono
OBJECTIVES: This study aimed to investigate the impact of left pulmonary artery stenting on outcomes after Fontan procedure in patients with single ventricle physiology. METHODS: Patients who underwent staged Fontan palliation between 1994 and 2023 were reviewed. The records of patients who had left pulmonary artery stents implanted were analysed, and their impact on outcomes after Fontan completion was evaluated. RESULTS: Among 601 patients who underwent staged Fontan completion during the study period, 64 patients (10.6%) had a left pulmonary artery stent implanted (19 before Glenn and 49 before Fontan). Patients with a left pulmonary artery stent exhibited higher pulmonary artery pressure (10 vs 9 mmHg, P = 0.005) and smaller left pulmonary artery diameter (5.7 vs 6.6 mm, P = 0.002) before Fontan. The left pulmonary artery stenting group had longer cardiopulmonary bypass times (75 vs 62 min, P = 0.006) and a higher incidence of prolonged effusion (17.2% vs 9.5%, P = 0.049) at Fontan. Long-term follow-up revealed higher rates of reintervention of the left pulmonary artery (P = 0.001), plastic bronchitis (P = 0.007) and failing Fontan (P = 0.008) in the patients with left pulmonary artery stenting compared to those without. Hypoplastic left heart syndrome (odds ratio = 2.65, P = 0.008) and patent ductus arteriosus stenting (odds ratio = 4.03, P = 0.002) were identified as independent risk factors for the need for left pulmonary artery stenting. CONCLUSIONS: A left pulmonary artery stent had been implanted in 10.6% of patients before Fontan completion. Left pulmonary artery stenting does not adversely affect survival but affects in-hospital morbidities and late morbidities of reintervention, plastic bronchiolitis, and failing Fontan.